BTIG’s 15 high conviction stocks for 2H

Abstract trading chart with big data and infographics. 3D Fintech concept background with glowing candle chart

da-kuk

BTIG analysts refreshed their top fundamental stock picks for the second half of the year.

These are the 15 high-conviction names, alongside some technical “color” by BTIG analysts.

All buy-rated:

Astrana Health, Inc. (ASTH) – Price target: $60

The stock

Leave a Reply

Your email address will not be published. Required fields are marked *